Glenmark Pharmaceuticals Sees 18.09% Surge in Open Interest Amid Increased Trading Activity
Glenmark Pharmaceuticals Ltd. has seen a significant rise in open interest, reaching 62,206 contracts, alongside a trading volume of 98,521 contracts. Despite underperforming its sector, the stock's delivery volume increased by 39.51%, indicating heightened trading activity and adequate liquidity in the market.
Glenmark Pharmaceuticals Ltd. has experienced a significant increase in open interest today, reflecting heightened activity in its trading. The latest open interest stands at 62,206 contracts, marking a notable rise of 9,531 contracts or 18.09% from the previous open interest of 52,675. This surge coincides with a trading volume of 98,521 contracts, indicating robust market engagement.In terms of price performance, Glenmark Pharmaceuticals has underperformed its sector by 3.21%. The stock opened lower today, with a decline of 2.14%, and reached an intraday low of Rs 1,810, representing a drop of 4.52%. The weighted average price suggests that more volume was traded closer to this low price point. While the stock remains above its 5-day and 200-day moving averages, it is currently below the 20-day, 50-day, and 100-day moving averages.
Additionally, delivery volume has seen a rise of 39.51% compared to the 5-day average, with a total delivery volume of 8.4 lakh shares on November 14. The liquidity of the stock remains adequate, supporting a trade size of Rs 4.81 crore based on 2% of the 5-day average traded value. Overall, the increase in open interest highlights a notable shift in trading dynamics for Glenmark Pharmaceuticals.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
